Healthcare / Medical: Diagnostics & Research
Thermo Fisher Scientific Inc.TMO
Thermo Fisher sells instruments, consumables and services to drug makers, labs, hospitals and industry, in four segments: Laboratory Products and Biopharma Services (lab supplies, contract drug manufacturing, clinical research), Life Sciences Solutions (reagents, bioproduction), Analytical Instruments (mass spectrometers, electron microscopes) and Specialty Diagnostics.
- Edition
- Nov 10, 2026
- Covers
- Q3 2026
- Length
- 8 pages
In This Report
- 1SummaryThe takeaway, the case for and what could go wrong
- 2Financial HealthSales, margins, cash flow and debt over the years
- 3Business TrendsThe segments and the operating numbers the company reports
- 4Dividend ProfileThe dividend's record, its growth, and how well cash and earnings cover it
- 5Yield HistoryToday's yield against its own five and ten-year range
- 6ValuationThe price against the stock's own history and the intrinsic value models
- 7Outlook and RisksAnalyst estimates, guidance and the risks to watch
- 8MethodologyGlossary, sources and disclosures